9 Meters Biopharma Shares Tumble 21% On Reverse Stock Split
marketwatch.com
news
2022-10-18 16:14:00

By Denny Jacob 9 Meters Biopharma Inc. shares tumbled 21% to $2.82 following a 1-for-20 reverse stock split. The clinical stage biopharmaceutical company began trading on a split adjusted basis on Tuesday. The reverse stock split became effective on Monday at 5 p.m. EDT. 9 Meters said the split is intended to bring the company into compliance with Nasdaq's minimum bid price requirement. The reverse split will reduce the number of shares of common stock issued and outstanding to roughly 13 million from 259.
